Apogee Therapeutics Inc (APGE) PT Raised to $95 at Stifel
Tweet Send to a Friend
Stifel analyst Alex Thompson raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $95.00 (from $46.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
